• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数据验证审核对医院死亡率排名和绩效薪酬的影响。

Effect of data validation audit on hospital mortality ranking and pay for performance.

机构信息

Pôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, Lyon, France

Health Services and Performance Research lab (HESPER EA7425), Université Claude Bernard Lyon 1, Lyon, France.

出版信息

BMJ Qual Saf. 2019 Jun;28(6):459-467. doi: 10.1136/bmjqs-2018-008039. Epub 2018 Oct 26.

DOI:10.1136/bmjqs-2018-008039
PMID:30366969
Abstract

BACKGROUND

Quality improvement and epidemiology studies often rely on database codes to measure performance or impact of adjusted risk factors, but how validity issues can bias those estimates is seldom quantified.

OBJECTIVES

To evaluate whether and how much interhospital administrative coding variations influence a typical performance measure (adjusted mortality) and potential incentives based on it.

DESIGN

National cross-sectional study comparing hospital mortality ranking and simulated pay-for-performance incentives before/after recoding discharge abstracts using medical records.

SETTING

Twenty-four public and private hospitals located in France PARTICIPANTS: All inpatient stays from the 78 deadliest diagnosis-related groups over 1 year.

INTERVENTIONS

Elixhauser and Charlson comorbidities were derived, and mortality ratios were computed for each hospital. Thirty random stays per hospital were then recoded by two central reviewers and used in a Bayesian hierarchical model to estimate hospital-specific and comorbidity-specific predictive values. Simulations then estimated shifts in adjusted mortality and proportion of incentives that would be unfairly distributed by a typical pay-for-performance programme in this situation.

MAIN OUTCOME MEASURES

Positive and negative predictive values of routine coding of comorbidities in hospital databases, variations in hospitals' mortality league table and proportion of unfair incentives.

RESULTS

A total of 70 402 hospital discharge abstracts were analysed, of which 715 were recoded from full medical records. Hospital comorbidity-level positive predictive values ranged from 64.4% to 96.4% and negative ones from 88.0% to 99.9%. Using Elixhauser comorbidities for adjustment, 70.3% of hospitals changed position in the mortality league table after correction, which added up to a mean 6.5% (SD 3.6) of a total pay-for-performance budget being allocated to the wrong hospitals. Using Charlson, 61.5% of hospitals changed position, with 7.3% (SD 4.0) budget misallocation.

CONCLUSIONS

Variations in administrative data coding can bias mortality comparisons and budget allocation across hospitals. Such heterogeneity in data validity may be corrected using a centralised coding strategy from a random sample of observations.

摘要

背景

质量改进和流行病学研究通常依赖于数据库代码来衡量调整后的风险因素的绩效或影响,但很少有量化的方法来确定有效性问题如何会产生偏差。

目的

评估医院间行政编码差异对典型绩效指标(调整后死亡率)和基于该指标的潜在激励措施的影响程度。

设计

全国性的病例对照研究,比较使用病历重新编码出院摘要前后医院死亡率排名和模拟按绩效付费激励措施。

地点

法国 24 家公立和私立医院。

参与者

一年内 78 个最致命的诊断相关组的所有住院患者。

干预措施

使用 Elixhauser 和 Charlson 共病进行分析,并计算每个医院的死亡率比值。然后,每个医院随机抽取 30 名住院患者,由两名中央审查员重新编码,并使用贝叶斯层次模型估计医院特异性和共病特异性预测值。模拟然后估计在这种情况下,典型的按绩效付费计划中调整后死亡率和不公平分配的激励措施比例的变化。

主要结果指标

医院数据库中常规共病编码的阳性和阴性预测值、医院死亡率排名表的变化以及不公平激励措施的比例。

结果

共分析了 70402 份医院出院摘要,其中 715 份从完整病历中重新编码。医院共病水平的阳性预测值范围为 64.4%至 96.4%,阴性预测值范围为 88.0%至 99.9%。使用 Elixhauser 共病进行调整后,70.3%的医院在死亡率排名表中位置发生了变化,这导致总绩效付费预算中错误分配给错误医院的金额增加了 6.5%(标准差为 3.6)。使用 Charlson 共病时,61.5%的医院位置发生了变化,预算分配错误为 7.3%(标准差为 4.0)。

结论

行政数据编码的差异会影响医院间的死亡率比较和预算分配。可以使用从观察到的随机样本进行集中编码策略来纠正数据有效性方面的这种异质性。

相似文献

1
Effect of data validation audit on hospital mortality ranking and pay for performance.数据验证审核对医院死亡率排名和绩效薪酬的影响。
BMJ Qual Saf. 2019 Jun;28(6):459-467. doi: 10.1136/bmjqs-2018-008039. Epub 2018 Oct 26.
2
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
3
Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.国际疾病分类第9版(ICD - 9)和第10版(ICD - 10)管理数据库中查尔森合并症和埃利克斯豪泽合并症的风险调整表现。
BMC Health Serv Res. 2008 Jan 14;8:12. doi: 10.1186/1472-6963-8-12.
4
Pay for performance, quality of care, and outcomes in acute myocardial infarction.急性心肌梗死的绩效薪酬、医疗质量与治疗结果
JAMA. 2007 Jun 6;297(21):2373-80. doi: 10.1001/jama.297.21.2373.
5
Role of pay-for-performance in a hospital performance measurement system: a multiple case study in Iran.按绩效付费在医院绩效测量系统中的作用:伊朗的多案例研究。
Health Policy Plan. 2013 Mar;28(2):206-14. doi: 10.1093/heapol/czs055. Epub 2012 Jun 17.
6
Length of stay as a source of bias in comparing performance in VA and private sector facilities: lessons learned from a regional evaluation of intensive care outcomes.在比较退伍军人事务部(VA)设施和私营部门设施的绩效时,住院时间作为偏差来源:从重症监护结果的区域评估中吸取的教训。
Med Care. 2001 Sep;39(9):1014-24. doi: 10.1097/00005650-200109000-00011.
7
[Hospital mortality and length of stay: comparison between public and private hospitals in Ribeirão Preto, São Paulo State, Brazil].[医院死亡率与住院时间:巴西圣保罗州里贝朗普雷图公立与私立医院的比较]
Cad Saude Publica. 2004;20 Suppl 2:S268-82. doi: 10.1590/s0102-311x2004000800021. Epub 2004 Dec 15.
8
Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives.患者病例组合调整、医院流程绩效排名与财务激励资格的关联。
JAMA. 2008 Oct 22;300(16):1897-903. doi: 10.1001/jama.300.16.1897.
9
Disease-Specific Trends of Comorbidity Coding and Implications for Risk Adjustment in Hospital Administrative Data.医院管理数据中合并症编码的疾病特异性趋势及其对风险调整的影响。
Health Serv Res. 2016 Jun;51(3):981-1001. doi: 10.1111/1475-6773.12398. Epub 2015 Oct 7.
10

引用本文的文献

1
End-of-life care for patients with pancreatic cancer in France: a nationwide population-based cohort study.法国胰腺癌患者的临终关怀:一项基于全国人口的队列研究。
Ther Adv Med Oncol. 2025 Feb 20;17:17588359251320731. doi: 10.1177/17588359251320731. eCollection 2025.
2
Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study.持续葡萄糖监测(CGM)指标能否预测糖尿病的大血管和微血管并发症?一项回顾性真实世界队列研究的FACULTY方案。
BMJ Open. 2025 Jan 8;15(1):e085961. doi: 10.1136/bmjopen-2024-085961.
3
A time-adjusted control chart for monitoring surgical outcome variations.
用于监测手术结果变化的时间调整控制图。
PLoS One. 2024 May 15;19(5):e0303543. doi: 10.1371/journal.pone.0303543. eCollection 2024.
4
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.2 型糖尿病患者的心血管和肾脏疾病:首次发病表现和住院费用的 5 年累积发生率:法国全国索赔数据库 SNDS 中的一个队列。
Cardiovasc Diabetol. 2024 Jan 9;23(1):22. doi: 10.1186/s12933-023-02101-1.
5
Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data.理解行政健康数据中不准确编码导致的脓毒症监测和质量保证的偏倚。
Infection. 2024 Apr;52(2):413-427. doi: 10.1007/s15010-023-02091-y. Epub 2023 Sep 9.
6
Economic analysis of surgical outcome monitoring using control charts: the SHEWHART cluster randomised trial.使用控制图进行手术结果监测的经济分析:休哈特整群随机试验
BMJ Qual Saf. 2024 Apr 24;33(5):284-292. doi: 10.1136/bmjqs-2022-015390.
7
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.稳定性冠心病合并 2 型糖尿病但无心肌梗死或卒史且类似 THEMIS 患者:来自法国全国索赔数据库的 SNDS 的真实世界主要结局的患病率和风险。
Cardiovasc Diabetol. 2021 Nov 25;20(1):229. doi: 10.1186/s12933-021-01416-1.
8
Mortality Among Noncoronavirus Disease 2019 Critically Ill Patients Attributable to the Pandemic in France.法国大流行期间非 2019 冠状病毒病危重症患者的死亡率。
Crit Care Med. 2022 Jan 1;50(1):138-143. doi: 10.1097/CCM.0000000000005215.
9
Effect of monitoring surgical outcomes using control charts to reduce major adverse events in patients: cluster randomised trial.使用控制图监测手术结果以减少患者主要不良事件的效果:整群随机试验。
BMJ. 2020 Nov 4;371:m3840. doi: 10.1136/bmj.m3840.